Natural EVs in cancer therapy. a) TEX stimulate immune activation by

Download scientific diagram | Natural EVs in cancer therapy. a) TEX stimulate immune activation by boosting T‐cell expansion and function via APCs especially DC cells. DEX activate T cells by mimicking the role of APCs. b) NK‐cell‐derived EVs induce tumor cell death through FasL, perforin, and TNF‐α. c) EVs from M1 macrophages can re‐educate tumor associated macrophages from M2 to M1 phenotype, which further activates anti‐tumor immunity. d) Stem‐cell‐derived EVs inhibit the growth of tumor cells through miRNA‐mediated mechanisms. Abbreviations: DC cell, dendritic cell; DEX, dendritic cell‐derived EVs; FasL, Fas ligand; M1 EVs, M1 macrophage‐derived EVs; MHC, major histocompatibility complex; MSCs, mesenchymal stem cells; NK EVs, NK cell‐derived EVs; TCR, T cell receptor; TEX, tumor cell‐derived EVs; TNF‐α, tumor necrosis factor‐α; TNFR, tumor necrosis factor receptor. from publication: Engineered Extracellular Vesicles for Cancer Therapy | Extracellular vesicles (EVs) have emerged as a novel cell-free strategy for the treatment of many diseases including cancer. As a result of their natural properties to mediate cell-to-cell communication and their high physiochemical stability and biocompatibility, EVs are | Extracellular Vesicles, Cancer Therapy and Bioinspired | ResearchGate, the professional network for scientists.

Full article: Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles

Cancers, Free Full-Text

Frontiers Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy

mRNA vaccine - Wikipedia

Engineered extracellular vesicles: potentials in cancer combination therapy, Journal of Nanobiotechnology

Extracellular Vesicle-Associated Proteins in Tissue Repair: Trends in Cell Biology

Full article: Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy

Profiling of Tumor-Infiltrating Immune Cells in Syngeneic Tumor Models to Support Drug Development

Exosomes and organ-specific metastasis - ScienceDirect

Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy - eBioMedicine

Full article: Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses

Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses